View in EDS

In silico assessment of cellular damage from Lu‐177, Ac‐225, and Pb‐212 therapeutic radionuclides.

Saved in:
Bibliographic Details
Title: In silico assessment of cellular damage from Lu‐177, Ac‐225, and Pb‐212 therapeutic radionuclides.
Authors: Chatzipapas, Konstantinos P.1,2,3 (AUTHOR), Papachristou, Konstantinos3 (AUTHOR), Visvikis, Dimitris2 (AUTHOR), Incerti, Sebastien4 (AUTHOR), Hazle, John D.5 (AUTHOR), Kagadis, George C.3,5 (AUTHOR) gkagad@gmail.com
Source: Medical Physics. Nov2025, Vol. 52 Issue 11, p1-13. 13p.
Subjects: DNA damage, Radioisotopes, Monte Carlo method, Cancer treatment, Beta rays, Radiopharmaceuticals
Abstract: Background: Targeted radionuclide therapy (TRT) has emerged as a unique and effective treatment modality for cancer. Monte Carlo simulations have greatly advanced investigations into radiation‐caused DNA damage, including the complexity of this damage. Purpose: This study aimed to evaluate DNA damage induced by high‐linear energy transfer therapeutic radionuclides used in TRT, specifically 225Ac, 177Lu, and 212Pb, using Geant4‐DNA Monte Carlo simulations. Methods: The Geant4‐DNA toolkit, incorporating the "molecularDNA" example, was employed to simulate radiation interactions within a human fibroblast cell model featuring a fractal chromatin fiber geometry within an ellipsoidal nucleus. Three source geometries (membrane, cytoplasm, nucleus) were modeled to assess the impact of radionuclide localization. Key metrics, including absorbed dose, double‐strand break (DSB) yield, single‐strand break/DSB ratio, and DSB/Gbp/decay, were calculated for 225Ac (alpha emitter), 177Lu (beta emitter), and 212Pb (mixed alpha/beta emitter). Simulations accounted for physical, physicochemical, and chemical stages, with validation against published data for 177Lu and 225Ac. Results: Alpha emitter 225Ac exhibited the highest DSB/Gbp/decay (1.646 in nucleus geometry) and absorbed dose (0.256 Gy/decay), followed by 212Pb (0.455 DSB/Gbp/decay, 0.0684 Gy/decay), and 177Lu (0.0058 DSB/Gbp/decay, 0.0007 Gy/decay). DSB yields increased with proximity to the nucleus, with 225Ac showing up to 284 times greater DSB/Gbp/decay than 177Lu. Validation showed < 10% divergence from reference studies. Conclusions: Geant4‐DNA simulations highlight the superior radiobiological effectiveness of alpha emitters, particularly 225Ac, for inducing DNA damage and emphasize the importance of source localization. These findings enhance our understanding of TRT's radiobiological effects and can be used to support development of refined therapeutic strategies. [ABSTRACT FROM AUTHOR]
Copyright of Medical Physics is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Engineering Source
Description
Abstract:Background: Targeted radionuclide therapy (TRT) has emerged as a unique and effective treatment modality for cancer. Monte Carlo simulations have greatly advanced investigations into radiation‐caused DNA damage, including the complexity of this damage. Purpose: This study aimed to evaluate DNA damage induced by high‐linear energy transfer therapeutic radionuclides used in TRT, specifically 225Ac, 177Lu, and 212Pb, using Geant4‐DNA Monte Carlo simulations. Methods: The Geant4‐DNA toolkit, incorporating the "molecularDNA" example, was employed to simulate radiation interactions within a human fibroblast cell model featuring a fractal chromatin fiber geometry within an ellipsoidal nucleus. Three source geometries (membrane, cytoplasm, nucleus) were modeled to assess the impact of radionuclide localization. Key metrics, including absorbed dose, double‐strand break (DSB) yield, single‐strand break/DSB ratio, and DSB/Gbp/decay, were calculated for 225Ac (alpha emitter), 177Lu (beta emitter), and 212Pb (mixed alpha/beta emitter). Simulations accounted for physical, physicochemical, and chemical stages, with validation against published data for 177Lu and 225Ac. Results: Alpha emitter 225Ac exhibited the highest DSB/Gbp/decay (1.646 in nucleus geometry) and absorbed dose (0.256 Gy/decay), followed by 212Pb (0.455 DSB/Gbp/decay, 0.0684 Gy/decay), and 177Lu (0.0058 DSB/Gbp/decay, 0.0007 Gy/decay). DSB yields increased with proximity to the nucleus, with 225Ac showing up to 284 times greater DSB/Gbp/decay than 177Lu. Validation showed < 10% divergence from reference studies. Conclusions: Geant4‐DNA simulations highlight the superior radiobiological effectiveness of alpha emitters, particularly 225Ac, for inducing DNA damage and emphasize the importance of source localization. These findings enhance our understanding of TRT's radiobiological effects and can be used to support development of refined therapeutic strategies. [ABSTRACT FROM AUTHOR]
ISSN:00942405
DOI:10.1002/mp.70089